AMAD_Log_vs_AMAE_Sta

Profile details

Identifier: MTBLS4046_0002_00000014
Linked study: MTBLS4046 — Transcriptional Shift and Metabolic Adaptations during Leishmania Quiescence Using Stationary Phase and Drug Pressure as Models
Comparison: AMAD_Log vs AMAE_Sta
Group A: Amastigote stage under Log treatment. Provides insight into the effects of Log treatment on amastigote stage.
Group B: Amastigote stage under Sta treatment. Provides insight into the effects of Sta treatment on amastigote stage.
Total features tested: 29
Significant features: 24
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
ONIBWKKTOPOVIA-BYPYZUCNSA-N	(2S)-pyrrolidinium-2-carboxylate	up	24.69	3.42e-05
DDRJAANPRJIHGJ-UHFFFAOYSA-N	créatinine	up	10.05	2.84e-05
TYEYBOSBBBHJIV-UHFFFAOYSA-N	α-ketobutyric acid	up	5.65	1.37e-05
KWIUHFFTVRNATP-UHFFFAOYSA-N	Bet	up	7.204	0.000205
MTCFGRXMJLQNBG-REOHCLBHSA-N	<small>L</small>-serine zwitterion	up	10.05	0.00168
DHMQDGOQFOQNFH-UHFFFAOYSA-N	aminoethanoic acid	up	7.109	0.000691
BTCSSZJGUNDROE-UHFFFAOYSA-N	GABA	up	7.091	0.000803
LRFVTYWOQMYALW-UHFFFAOYSA-N	Xanthine	down	0.1497	0.00128
UGQMRVRMYYASKQ-KQYNXXCUSA-N	hypoxanthine <small>D</small>-riboside	up	2.836	1.02e-05
FFEARJCKVFRZRR-BYPYZUCNSA-N	L-Methionine	up	3.432	0.000183